Valeant Pharmaceuticals International (VRX) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free VRX Stock Alerts C$30.80 -1.06 (-3.33%) (As of 07/13/2018) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative February 2, 2024 | finance.yahoo.comValeant Pharmaceuticals International, Inc. (VRX.TO)May 5, 2023 | uk.finance.yahoo.comBranded Generics Global Market Report 2023March 18, 2023 | thestreet.comValeant Pharmaceuticals International Stock Hits New 52-Week High (VRX)March 10, 2023 | thestreet.comValeant Pharmaceuticals International Inc (VRX): Today's Featured Health Care LoserDecember 26, 2022 | thestreet.comValeant Pharmaceuticals International Stock Gaps Up On Today's Open (VRX)August 26, 2022 | thestreet.comValeant Shaves Another Chunk From Its Crushing Debt Load, Shares Continue March HigherAugust 22, 2022 | thestreet.comDespite Woes, Valeant May Be Headed for a ReboundApril 30, 2022 | thestreet.comJPMorgan Picks 7 Pharmaceutical Stocks to Buy (or Hold) in Wake of Interest Rates HikeNovember 17, 2021 | finance.yahoo.comValeant Pharmaceuticals International, Inc. (VRX) Get Valeant Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for VRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… VRX Media Mentions By Week VRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRX News Sentiment▼0.000.42▲Average Medical News Sentiment VRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRX Articles This Week▼00▲VRX Articles Average Week Get Valeant Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for VRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BHC News TLRY News CRON News WEED News GUD News ACB News OGI News CPH News CRDL News HLS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:VRX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA once-in-a-century investment opportunityStansberry ResearchDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valeant Pharmaceuticals International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.